Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.26 - $0.64 $2,785 - $6,856
10,713 New
10,713 $3,000
Q1 2022

May 16, 2022

SELL
$0.52 - $1.0 $6,552 - $12,600
-12,600 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$0.85 - $1.33 $497 - $778
-585 Reduced 4.44%
12,600 $12,000
Q3 2021

Nov 15, 2021

SELL
$1.03 - $1.41 $10,379 - $14,208
-10,077 Reduced 43.32%
13,185 $17,000
Q2 2021

Aug 16, 2021

SELL
$1.04 - $1.5 $127,360 - $183,693
-122,462 Reduced 84.04%
23,262 $26,000
Q1 2021

May 17, 2021

BUY
$0.84 - $2.16 $122,408 - $314,763
145,724 New
145,724 $170,000
Q4 2020

Feb 16, 2021

SELL
$0.65 - $1.11 $78,915 - $134,763
-121,409 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$0.48 - $0.84 $51,527 - $90,172
107,348 Added 763.44%
121,409 $99,000
Q2 2020

Aug 14, 2020

BUY
$0.43 - $0.74 $6,046 - $10,405
14,061 New
14,061 $8,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.